Business

mass. movers

Repligen’s revenue slides 18.2 percent

For fiscal 2014, Repligen sees $54 million to $57 million in revenue and net income of $7 million to $9 million.
New York Times/File 2006
For fiscal 2014, Repligen sees $54 million to $57 million in revenue and net income of $7 million to $9 million.

Waltham-based Repligen Corp., which produces products used in the manufacturing of biological drugs, reported quarterly revenue of $15.4 million, an 18.2 percent decrease from the year-earlier quarter, as adjusted earnings per share fell to 10 cents from 30 cents. Wall Street estimates had called for $15.9 million in revenue and 14 cents in per-share earnings. If there was a bright spot, Motley Fool reported, it was that bioprocessing revenue jumped nearly 7 percent to $10.4 million.

Advertisement